Skip to Main Content
Drug Law Enforcement, Policing and Harm Reduction: Ending the Stalemate
The policing of drugs is an intriguing, complex, and contentious domain that brings into sharp focus the multifaceted nature of the police role and has farreaching consequences for health, crime, and justice. While research on drugs policing has historically been surprisingly sparse, fragmented, and underdeveloped, the field has recently become a burgeoning area of academic study, influenced by contemporary trends in policing practices, changes in drug policy, and wider social movements. This book makes a much-needed interdisciplinary and international contribution that engages with established and emerging areas of scholarship, advances cutting-edge debates, and sets an agenda for future directions in drugs policing.
12 Month-ending Provisional Number of Drug Overdose Deaths (CDC)
This data visualization presents provisional counts for drug overdose deaths based on a current flow of mortality data in the National Vital Statistics System. Counts for the most recent final annual data are provided for comparison. National provisional counts include deaths occurring within the 50 states and the District of Columbia as of the date specified and may not include all deaths that occurred during a given time period.
Drug Industry Documents (UCSF)
An archive of documents created by major pharmaceutical companies related to their advertising, manufacturing, marketing, sales and scientific research, hosted by the UCSF Library.
Opioid Industry Documents Archive (UCSF and Johns Hopkins University)
The documents, the majority of which became public as a result of a lawsuit filed by The Washington Post and the Charleston Gazette, include emails, memos, presentations, sales reports, budgets, audit reports, Drug Enforcement Administration briefings, meeting agendas and minutes, expert witness reports, and depositions of drug company executives. The archive serves as a living repository of information that can be used to learn from the opioid epidemic so as to improve and safeguard public policy and public health, and to ensure that the opioid-related harms that have taken place never occur again.
What America's Users Spend on Illegal Drugs, 2006–2016 (RAND Corporation, 2019)
This report updates and extends estimates of the number of users, retail expenditures, and amount consumed from 2006 to 2016 for cocaine (including crack), heroin, marijuana, and methamphetamine in the United States, based on a methodology developed by the RAND Corporation for the Office of National Drug Control Policy. The report also includes a discussion of what additional types of data would help quantify the scale of these markets in the future, including the new types of information produced by the legalization of marijuana at the state level.
Anthropology/Sociology & interim Philosophy Librarian